Status: Recruiting
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
A multi-center evaluation of NGM120 in a randomized, double-blind, placebo-controlled study in participants with colorectal cancer who have cancer cachexia.
Participants needed: 136
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: NGM Biopharmaceuticals, IncUpdated: Apr 1, 2026Locations: 28
Eligibility criteria
Documented active diagnosis of colorectal cancer. [+2]
Current active reversible causes of decreased food intake. [+2]